LEXINGTON, Mass.–(BUSINESS WIRE)–Cognesy Therapeutics, a recently established company developing a platform for the discovery of neuroplasticity-inducing drugs to treat a wide range of neuropsychiatric disorders, announced appointments of its senior leadership team, the company said today. The company seeks to address the worldwide medical need for novel therapeutics to treat central nervous system diseases, such…